Design and synthesis of novel pyrazolidine-3,5-diones derivatives

来源 :全国药物化学学术会议暨第四届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:fengk9000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  The pyrazolidine-3,5-diones,as an important heterocyclic compounds,have represent excellent biological activities such as anti-tumor[1],ant-cardiovascular,antibacterial,antiviral activities.
其他文献
他汀类降血脂药物是一种3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂,可阻断HMG-CoA 转变为胆固醇前体甲羟戊酸,并反馈性激活肝脏低密度脂蛋白受体(LDLR),使肝脏胆固醇合成受阻,引起细胞内胆固醇减少,从而显著降低血清总胆固醇(TC)及低密度脂蛋白胆固醇浓度[1].现有的他汀类药物(如:洛伐他丁、辛伐他汀、氟伐他汀、阿托伐他汀、罗素伐他汀等)分子结构中都包含有(3R,5R)-二
A number of research groups have attempted to determine the absolute configuration of(+)-mefloquine hydrochloride since 1974.Very surprisingly,its absolute configuration is controversial for nearly 40
会议
合成系列新的查尔酮衍生物,对其抑制beta-Amyloid(Aβ)聚集的活性进行研究,大部分化合物的抑制活性都比母体化合物好.其中分子式为C21H21NO5 的化合物4d(图1)具有很好的抑制Aβ(1-42)自聚集的活性,IC50 = 2.2 ± 1.5μM[1].为了研究化合物抑制Aβ 聚集的机制,我们利用计算机辅助进行分子对接和分子动力学研究,对化合物的结合模式和结合能量以及Ab蛋白23~28
We have recently prepared O-and S-glycosyl aryl boronic acids,which are proved as viable material for further applications.We demonstrate hereby that these compounds are useful in organic synthesis an
A series of new isoliquiritigenin(ISL)derivatives were synthesized and evaluated as inhibitors for amyloid-beta(Aβ)aggregation.It was found that all these synthetic compounds inhibited Aβ(1-42)self-ag
G-四链体是新型抗肿瘤药物的有效作用靶点之一.至今已开发的G-四链体配体分子多以π-π堆积的方式作用于末端G-四集体上,但由于同样对双链DNA有一定的亲和力而带来副作用.一些氨基糖类可以特异性识别G-四链体的沟区和(或)loop.基于此,我们设计了一类新型的G-四链体配体分子,采用柔性连接策略,将经典的平面型核酸嵌入剂分子(如吖啶类的原黄素,Proflavine),通过不同长度的连接臂,与不同大小
会议
NM23-H2 protein is identified as a transcriptional factor of the important oncogene c-myc,that can bind specifically to defined DNA sequences to promote gene transcription.However,due to its role in t
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies,a series of novel DAPY derivatives were rationally designed,synthesized and evaluated for their anti-HIV activities
Multikinase inhibitors have emerged as new approaches for cancer therapy in recent years,notonly for their outstanding antitumor activities,but also for their diverse mechanisms of action exertedin di
会议
Nitrogen-containing heterocyclic compounds have received much attention as shown by the numerous studies published on their applicability in different areas,especially as drugs1.